Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2015 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | ||||
| Depreciation Amortization | 88 | 79 | N/A | N/A |
| Accounts receivable | -129 | -727 | N/A | N/A |
| Other Working Capital | 124 | -431 | 46 | 0 |
| Other Operating Activity | -1,669 | -408 | -55 | 0 |
| Operating Cash Flow | $-1,586 | $-1,487 | $-9 | $0 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -9 | -10 | N/A | N/A |
| Sale Of Investment | 40 | 67 | N/A | N/A |
| Purchase Sale Intangibles | -98 | -115 | N/A | N/A |
| Other Investing Activity | 141 | 0 | 0 | 0 |
| Investing Cash Flow | $74 | $-58 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 778 | 817 | N/A | N/A |
| Debt Repayment | -577 | -25 | N/A | N/A |
| Common Stock Issued | 6,432 | 5,930 | 302 | 392 |
| Other Financing Activity | 0 | 0 | -126 | -28 |
| Financing Cash Flow | $6,633 | $6,722 | $176 | $364 |
| Exchange Rate Effect | 0 | -7 | N/A | N/A |
| Beginning Cash Position | 473 | 563 | 374 | 0 |
| End Cash Position | 5,594 | 5,733 | 541 | 364 |
| Net Cash Flow | $5,121 | $5,177 | $167 | $364 |
| Free Cash Flow | ||||
| Operating Cash Flow | -1,586 | -1,487 | -9 | 0 |
| Capital Expenditure | -107 | -125 | N/A | N/A |
| Free Cash Flow | -1,693 | -1,612 | -9 | 0 |